Edition:
United States

Fate Therapeutics Inc (FATE.OQ)

FATE.OQ on NASDAQ Stock Exchange Global Market

11.27USD
23 May 2018
Change (% chg)

$0.40 (+3.68%)
Prev Close
$10.87
Open
$10.76
Day's High
$11.47
Day's Low
$10.76
Volume
100,311
Avg. Vol
206,002
52-wk High
$14.45
52-wk Low
$2.54

Select another date:

Thu, May 10 2018

BRIEF-Fate Therapeutics Qtrly Loss Per Share $0.27

* FATE THERAPEUTICS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND HIGHLIGHTS OPERATIONAL PROGRESS

BRIEF-Fate Therapeutics Files For Mixed Shelf Of Up To $150 Million

* FATE THERAPEUTICS INC FILES FOR MIXED SHELF OF UP TO $150 MILLION – SEC FILING Source text: (https://bit.ly/2KD5gGz) Further company coverage:

BRIEF-Fate Therapeutics Announces Additional Clinical Data From Phase 1 Stage Of Protect Clinical Trial Of Protmune

* FATE THERAPEUTICS ANNOUNCES ADDITIONAL CLINICAL DATA FROM PHASE 1 STAGE OF PROTECT CLINICAL TRIAL OF PROTMUNE™

BRIEF-Fate Therapeutics Q4 Loss Per Share $0.29​

* FATE THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND HIGHLIGHTS OPERATIONAL PROGRESS

Select another date: